Blood transcriptomic markers for major depression: From animal models to clinical settings

Annals of the New York Academy of Sciences

Volumn 1344, Issue 1, 2015, Pages 37-49

  Redei, Eva E ^a   Mehta, Neha S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Animal models of depression; Blood transcripts; Early onset major depression; Gene expression; Major depression; Selective breeding

Indexed keywords

BIOLOGICAL MARKER; RNA;

ADULT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BLOOD LEVEL; CHRONIC STRESS; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; ENVIRONMENTAL STRESS; GENE EXPRESSION; GENETIC MODEL; HUMAN; MAJOR DEPRESSION; NONHUMAN; ONSET AGE; ORTHOLOGY; PILOT STUDY; PRIMARY MEDICAL CARE; TRANSCRIPTOMICS; ADOLESCENT; ANIMAL; ANXIETY DISORDERS; BLOOD; DEPRESSIVE DISORDER, MAJOR; DISEASE MODEL; FEMALE; GENE EXPRESSION PROFILING; PATHOPHYSIOLOGY; PROCEDURES;

ANIMALIA;

ADOLESCENT; ADULT; ANIMALS; ANXIETY DISORDERS; BIOLOGICAL MARKERS; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; PILOT PROJECTS; RNA;

EID: 84928241086     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12748     Document Type: Article

References (77)

1. Trivedi, M.H. et al. 2006. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatry 163: 28-40.
2. Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium. 2013. A mega-analysis of genome-wide association studies for major depressive disorder. Mol. Psychiatry 18: 497-511.
3. Sullivan, P.F. 2010. The psychiatric GWAS consortium: big science comes to psychiatry. Neuron 68: 182-186.
4. Liew, C.C. et al. 2006. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J. Lab. Clin. Med. 147: 126-132.
5. Sullivan, P.F., C. Fan & C.M. Perou . 2006. Evaluating the comparability of gene expression in blood and brain. Am. J. Med. Genet. 141B: 261-268.
6. Rollins, B. et al. 2010. Analysis of whole genome biomarker expression in blood and brain. Am. J. Med. Genet. 153B: 919-936.
7. Lai, C.Y. et al. 2011. MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. PLoS One 6: e21635.
8. Kuzman, M.R. et al. 2009. Genome-wide expression analysis of peripheral blood identifies candidate biomarkers for schizophrenia. J. Psychiat. Res. 43: 1073-1077.
9. Tsuang, M.T. et al. 2005. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am. J. Med. Genet. 133B: 1-5.
10. Pare, W.P. 1994. Open field, learned helplessness, conditioned defensive burying, and forced-swim tests in WKY rats. Physiol. Behav. 55: 433-439.
11. Solberg, L.C. et al. 2004. Sex- and lineage-specific inheritance of depression-like behavior in the rat. Mamm. Genome 15: 648-662.
12. Dugovic, C. et al. 2000. Sleep in the Wistar-Kyoto rat, a putative genetic animal model for depression. Neuroreport 11: 627-631.
13. Baum, A.E. et al. 2006. Test- and behavior-specific genetic factors affect WKY hypoactivity in tests of emotionality. Behav. Brain Res. 169: 220-230.
14. Nam, H. et al. 2014. Learned helplessness and social avoidance in the Wistar-Kyoto rat. Front. Behav. Neurosci. 8: 109.
15. Shi, J. et al. 2011. Genome-wide association study of recurrent early-onset major depressive disorder. Mol. Psychiatry 16: 193-201.
16. Malkesman, O. et al. 2006. Two different putative genetic animal models of childhood depression. Biol. Psychiatry 59: 17-23.
17. Liu, D. et al. 2014. Attenuated inhibition of medium spiny neurons participates in the pathogenesis of childhood depression. Neural Regenerat. Res. 9: 1079-1088.
18. Schaffer, D.J. et al. 2010. Nuclear orphan receptor Nor-1 contributes to depressive behavior in the Wistar-Kyoto rat model of depression. Brain Res. 1362: 32-39.
19. Tizabi, Y. et al. 2012. Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female Wistar-Kyoto rats. Neuroscience 213: 72-80.
20. Jeannotte, A.M. et al. 2009. Desipramine modulation of alpha-, gamma-synuclein, and the norepinephrine transporter in an animal model of depression. Neuropsychopharmacology 34: 987-998.
21. Brownea, C.A., vanNesta, D.S. & Lucki, I. 2015. Antidepressant-like effects of buprenorphine in rats are strain dependent. Behav. Brain Res. 278: 385-392.
22. Belujon, P. & A.A. Grace . 2014. Restoring mood balance in depression: ketamine reverses deficit in dopamine-dependent synaptic plasticity. Biol. Psychiatry 76: 927-936.
23. Kyeremanteng, C. et al. 2012. A study of brain and serum brain-derived neurotrophic factor protein in Wistar and Wistar-Kyoto rat strains after electroconvulsive stimulus. Pharmacopsychiatry 45: 244-249.
24. Kyeremanteng, C. et al. 2014. Effects of electroconvulsive seizures on depression-related behavior, memory and neurochemical changes in Wistar and Wistar-Kyoto rats. Progress Neuro-Psychopharmacol. Biol. Psychiatry 54: 170-178.
25. Falowski, S.M. et al. 2011. An evaluation of neuroplasticity and behavior after deep brain stimulation of the nucleus accumbens in an animal model of depression. Neurosurgery 69: 1281-1290.
26. Will, C.C., F. Aird & E.E. Redei . 2003. Selectively bred Wistar-Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants. Mol. Psychiatry 8: 925-932.
27. Andrus, B.M. et al. 2012. Gene expression patterns in the hippocampus and amygdala of endogenous depression and chronic stress models. Mol. Psychiatry 17: 49-61.
28. Williams, K.A. et al. 2012. Resting state functional MRI in a rat model of major depressive disorder, Program No. 827.11. 2012 Neuroscience Meeting Planner. New Orleans, LA.
29. Hasler, G. & G. Northoff . 2011. Discovering imaging endophenotypes for major depression. Mol. Psychiatry 16: 604-619.
30. Mehta, N.S., L. Wang & E.E. Redei . 2013. Sex differences in depressive, anxious behaviors and hippocampal transcript levels in a genetic rat model. Genes Brain Behav. 12: 695-704.
31. Wood, G.E. et al. 2008. Chronic immobilization stress alters aspects of emotionality and associative learning in the rat. Behav. Neurosci. 122: 282-292.
32. Bravo, J.A. et al. 2009. Desipramine prevents stress-induced changes in depressive-like behavior and hippocampal markers of neuroprotection. Behav. Pharmacol. 20: 273-285.
33. Gil, M., J. Marti & A. Armario . 1992. Inhibition of catecholamine synthesis depresses behavior of rats in the holeboard and forced swim tests: influence of previous chronic stress. Pharmacol. Biochem. Behav. 43: 597-601.
34. Joo, Y. et al. 2009. Chronic immobilization stress induces anxiety- and depression-like behaviors and decreases transthyretin in the mouse cortex. Neurosci. Lett. 461: 121-125.
35. Kim, K.S. & P.L. Han . 2006. Optimization of chronic stress paradigms using anxiety- and depression-like behavioral parameters. J. Neurosci. Res. 83: 497-507.
36. Haenisch, B. et al. 2009. Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression. J. Neurochem. 111: 403-416.
37. Veena, J. et al. 2009. Exposure to enriched environment restores the survival and differentiation of new born cells in the hippocampus and ameliorates depressive symptoms in chronically stressed rats. Neurosci. Lett. 455: 178-182.
38. Lee, T. et al. 2009. Chronic stress selectively reduces hippocampal volume in rats: a longitudinal magnetic resonance imaging study. Neuroreport 20: 1554-1558.
39. Thomas, M.A. et al. 2003. Phylogenetics of rat inbred strains. Mamm. Genome 14: 61-64.
40. Gomez, F. et al. 1996. Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains: differential responses are mainly located at the adrenocortical level. Neuroendocrinology 63: 327-337.
41. Natelson, B.H. et al. 1988. Effect of stressor intensity on habituation of the adrenocortical stress response. Physiol. Behav. 43: 41-46.
42. Gray, M., B. Bingham & V. Viau . 2010. A comparison of two repeated restraint stress paradigms on hypothalamic-pituitary-adrenal axis habituation, gonadal status and central neuropeptide expression in adult male rats. J. Neuroendocrinol. 22: 92-101.
43. Ruys, J.D. et al. 2004. Behavioral and physiological adaptation to repeated chair restraint in rhesus macaques. Physiol. Behav. 82: 205-213.
44. Gray, J.M., F. Chaouloff & M.N. Hill . 2015. To stress or not to stress: a question of models. Curr. Protoc. Neurosci. 70: 83331-383322.
45. Pajer, K. et al. 2012. Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression. Transl. Psychiatry 2: e101.
46. Solberg, L.C. et al. 2003. Depressive-like behavior and stress reactivity are independent traits in a Wistar Kyoto x Fisher 344 cross. Mol. Psychiatry 8: 423-433.
47. Merikangas, K.R. et al. 2010. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A). J. Am. Acad. Child Adolesc. Psychiatry 49: 980-989.
48. Lewinsohn, P.M. et al. 2003. Psychosocial functioning of young adults who have experienced and recovered from major depressive disorder during adolescence. J. Abnorm. Psychol. 112: 353-363.
49. Aalto-Setala, T. et al. 2002. Depressive symptoms in adolescence as predictors of early adulthood depressive disorders and maladjustment. Am. J. Psychiatry 159: 1235-1237.
50. Wilson, S. et al. 2014. Premorbid risk factors for major depressive disorder: are they associated with early onset and recurrent course? Develop. Psychopathol. 26: 1477-1493.
51. Redei, E.E. et al. 2014. Blood transcriptomic biomarkers in adult primary care patients with major depressive disorder undergoing cognitive behavioral therapy. Transl. Psychiatry 4: e442.
52. Wray, N.R. et al. 2012. Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. Mol. Psychiatry 17: 36-48.
53. Stergiakouli, E. et al. 2014. Genome-wide association study of height-adjusted BMI in childhood identifies functional variant in ADCY3. Obes. (Silver Spring). 22: 2252-2259.
54. Gulbins, E. et al. 2013. Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs. Nat. Med. 19: 934-938.
55. Selye, H. 1936. Thymus and Adrenals in the Response of the Organism to Injuries and Intoxications. Br. J. Exp. Pathol. 17: 234-248.
56. Armario, A. et al. 1987. Age-dependent effects of acute and chronic intermittent stresses on serum metallothionein. Physiol. Behav. 39: 277-279.
57. Chiba, S. et al. 2012. Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex. Progr. Neuro-Psychopharmacol. Biol. Psychiatry 39: 112-119.
58. McEwen, B.S. 2001. Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann. N. Y. Acad. Sci. 933: 265-277.
59. Naert, G. et al. 2011. Brain-derived neurotrophic factor and hypothalamic-pituitary-adrenal axis adaptation processes in a depressive-like state induced by chronic restraint stress. Mol. Cellular Neurosci. 46: 55-66.
60. Gameiro, G.H. et al. 2006. Nociception- and anxiety-like behavior in rats submitted to different periods of restraint stress. Physiol. Behav. 87: 643-649.
61. Hoffman, A.N. et al. 2014. Chronic stress disrupts fear extinction and enhances amygdala and hippocampal Fos expression in an animal model of post-traumatic stress disorder. Neurobiol. Learn. Memory 112: 139-147.
62. Sapolsky, R.M., L.C. Krey & B.S. McEwen . 1986. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocrine Rev. 7: 284-301.
63. Fava, M. et al. 2000. Anxiety disorders in major depression. Comprehens. Psychiatry 41: 97-102.
64. Campbell, D.G. et al. 2007. Prevalence of depression-PTSD comorbidity: implications for clinical practice guidelines and primary care-based interventions. J. Gen. Internal Med. 22: 711-718.
65. Panza, F. et al. 2010. Late-life depression, mild cognitive impairment, and dementia: possible continuum? Am. J. Geriatric Psychiatry 18: 98-116.
66. Zilkens, R.R. et al. 2014. Severe psychiatric disorders in mid-life and risk of dementia in late- life (age 65-84 years): a population based case-control study. Curr. Alzheimer Res. 11: 681-693.
67. O'Mahony, C.M. et al. 2011. Strain differences in the neurochemical response to chronic restraint stress in the rat: relevance to depression. Pharmacol. Biochem. Behav. 97: 690-699.
68. Zhu, S. et al. 2014. Unpredictable chronic mild stress not chronic restraint stress induces depressive behaviours in mice. Neuroreport 25: 1151-1155.
69. Yehuda, R. & J.D. Flory . 2007. Differentiating biological correlates of risk, PTSD, and resilience following trauma exposure. J. Trauma. Stress 20: 435-447.
70. Curry, J. et al. 2006. Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). J. Am. Acad. Child Adolesc. Psychiatry 45: 1427-1439.
71. Fava, M. et al. 2008. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am. J. Psychiatry 165: 342-351.
72. Eaton, W.W. et al. 2008. Population-based study of first onset and chronicity in major depressive disorder. Arch. Gen. Psychiatry 65: 513-520.
73. Leuchter, A.F. et al. 2009. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Res. 169: 124-131.
74. Labermaier, C., M. Masana & M.B. Muller . 2013. Biomarkers predicting antidepressant treatment response: how can we advance the field? Dis. Markers 35: 23-31.
75. National Institute of Mental Health. 2008. The National Institute of Mental Health Strategic Plan. In http://www.nimh.nih.gov/about/strategic-planning-reports/.
76. Singh, I. & N. Rose . 2009. Biomarkers in psychiatry. Nature 460: 202-207.
77. Stafford, R.S., E.A. MacDonald & S.N. Finkelstein . 2001. National patterns of medication treatment for depression, 1987 to 2001. Primary Care Companion J. Clin. Psychiatry 3: 232-235.